Unity Biotechnology
Public companyUS1 field
Where it works
| Technology | ||
|---|---|---|
| Longevity biotechDeveloped senolytic drugs such as UBX1325 for eye disease; stockholders approved its dissolution in 2025. | Developed senolytic drugs such as UBX1325 for eye disease; stockholders approved its dissolution in 2025. | unitybiotechnology.com |
Events
| Date | Event | ||
|---|---|---|---|
| Sep 18, 2025 | Unity Biotechnology stockholders approve dissolutionsec.gov· Announcement· Longevity biotech | Longevity biotech | Announcement |
| May 2, 2025 | Unity Biotechnology cuts all staff after ASPIRE datasec.gov· Announcement· Longevity biotech | Longevity biotech | Announcement |
| Apr 22, 2025 | Senolytic UBX1325 results for diabetic macular edema publisheddoi.org· Breakthrough· Longevity biotech | Longevity biotech | Breakthrough |
About
- Source
- unitybiotechnology.com (official, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Sep 25, 2026
| Date | Change | ||
|---|---|---|---|
| Sep 25, 2026 | Unity BiotechnologyCompany in Longevity biotech: Joined a field, Developed senolytic drugs such as UBX1325 for eye disease; stockholders approved its dissolution in 2025. | seed | unitybiotechnology.com |
| Sep 25, 2026 | Unity BiotechnologyCompany: Added | seed | unitybiotechnology.com |